Lucile Garidou
Pfizer (France)(FR)
Publications by Year
Research Areas
Acne and Rosacea Treatments and Effects, Gut microbiota and health, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Dermatology and Skin Diseases
Most-Cited Works
- → Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response(2016)313 cited
- → The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease(2015)291 cited
- → Estradiol enhances primary antigen‐specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor α expression in hematopoietic cells(2003)281 cited
- → Defective NOD 2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance(2015)188 cited
- → Immuno-microbiota cross and talk: The new paradigm of metabolic diseases(2012)143 cited
- → Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest(2009)129 cited
- → Metagenome and metabolism: the tissue microbiota hypothesis(2013)126 cited
- → Estrogen Enhances Susceptibility to Experimental Autoimmune Myasthenia Gravis by Promoting Type 1-Polarized Immune Responses(2005)121 cited
- → Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism(2013)106 cited
- → Estrogen Receptor α Signaling in Inflammatory Leukocytes Is Dispensable for 17β-Estradiol-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis(2004)80 cited